Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Einstein (Sao Paulo). 2022 May 6;20:eAO6758. doi: 10.31744/einstein_journal/2022AO6758. eCollection 2022.
Investigate pulse wave velocity and central systolic blood pressure among pediatric population with chronic kidney disease.
In this cross-sectional study, 57 patients (61.4% male) aged 6.2 to 17.5 years old, 44 with nondialysis chronic kidney disease and 13 on chronic dialysis, were included in the analysis. The pulse wave velocity and the central systolic blood pressure were measured with an oscillometric device with an inbuilt ARC SolverⓇ algorithm and were compared with previously established percentiles.
The prevalence of elevated pulse wave velocity was 21.1% (95%Cl: 11.4-33.9) and elevated central systolic blood pressure was 28.1% (95%CI: 17.0-41.5). According to the generalized linear model, there was a higher risk of elevated pulse wave velocity in patients undergoing chronic dialysis treatment than nondialysis chronic kidney disease patients (adjPR=4.24, 95%CI: 1.97-9.13, p=<0.001). Hypertensive patients (stage 2) had a higher risk of elevated pulse wave velocity than normotensive ones (adjPR=2.70, 95%CI: 1.05-6.95, p=0.040), as did patients younger than 12 years than the older patients (adjPR=2.95, 95%CI: 1.05-8.40, p=0.041). Hypertensive patients had a higher risk of elevated central systolic blood pressure than normotensives (adjPR=3.29, 95%Cl: 1.36-7.94), as did patients undergoing chronic dialysis treatment when comparing to nondialysis chronic kidney disease patients (adjPR=2.08, 95%Cl: 1.07-4.02).
Younger age, dialysis, and hypertension in children are independently associated with higher pulse wave velocity. Hypertension and dialysis are independently associated with higher central systolic blood pressure.
研究慢性肾脏病患儿的脉搏波速度和中心收缩压。
在这项横断面研究中,共纳入 57 名年龄在 6.2 至 17.5 岁的患儿(男性占 61.4%),其中 44 名患儿患有非透析慢性肾脏病,13 名患儿进行慢性透析。采用内置 ARC Solver Ⓡ 算法的振荡测量仪测量脉搏波速度和中心收缩压,并与预先建立的百分位数进行比较。
脉搏波速度升高的患病率为 21.1%(95%CI:11.4-33.9),中心收缩压升高的患病率为 28.1%(95%CI:17.0-41.5)。根据广义线性模型,与非透析慢性肾脏病患者相比,进行慢性透析治疗的患者发生脉搏波速度升高的风险更高(调整后的优势比[adjPR]=4.24,95%CI:1.97-9.13,p<0.001)。与血压正常的患者相比,高血压(2 期)患者发生脉搏波速度升高的风险更高(adjPR=2.70,95%CI:1.05-6.95,p=0.040),年龄小于 12 岁的患者比年龄较大的患者发生脉搏波速度升高的风险更高(adjPR=2.95,95%CI:1.05-8.40,p=0.041)。与血压正常的患者相比,高血压患者发生中心收缩压升高的风险更高(adjPR=3.29,95%Cl:1.36-7.94),与非透析慢性肾脏病患者相比,进行慢性透析治疗的患者发生中心收缩压升高的风险更高(adjPR=2.08,95%Cl:1.07-4.02)。
儿童的年龄较小、透析治疗和高血压与脉搏波速度升高独立相关。高血压和透析与中心收缩压升高独立相关。